Other
Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
West Pharmaceutical Services Reclassification From Aoci Current Period Net Of Tax Attributable To Parent decreased by 266.7% to -$500.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 66.7%, from -$300.00K to -$500.00K.
Analysis
StatementCash Flow Statement
SectionOther
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ1 2021
Last reportedQ1 2026Apr 23, 2026
How to read this metric
A large reclassification indicates the realization of past hedging or currency gains/losses, which may temporarily inflate or deflate current period net income.
Detailed definition
This metric tracks the amount of previously unrealized gains or losses that are moved from accumulated other comprehensi...
Peer comparison
Common in companies with significant hedging programs or international operations.
Metric ID:
other_reclassification_from_aoci_current_period_net_of_t_397f1eHistorical Data
13 periods
| Q2 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$2.60M | -$800.00K | -$200.00K | -$13.40M | -$400.00K | -$2.20M | -$3.30M | -$1.00M | -$400.00K | -$300.00K | -$300.00K | $300.00K | -$500.00K |
| QoQ Change | — | +69.2% | +75.0% | <-999% | +97.0% | -450.0% | -50.0% | +69.7% | +60.0% | +25.0% | +0.0% | +200.0% | -266.7% |
| YoY Change | — | — | +92.3% | — | +50.0% | <-999% | +75.4% | -150.0% | +81.8% | +90.9% | +70.0% | +200.0% | -66.7% |
Range-$13.40M – $300.00K
CAGR-42.3%
Avg YoY Growth-55.6%
Median YoY Growth+72.7%
Reclassification From Aoci Current Period Net Of Tax Attributable To Parent at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's reclassification from aoci current period net of tax attributable to parent?
- West Pharmaceutical Services (WST) reported reclassification from aoci current period net of tax attributable to parent of -$500.00K in Q1 2026.
- How has West Pharmaceutical Services's reclassification from aoci current period net of tax attributable to parent changed year-over-year?
- West Pharmaceutical Services's reclassification from aoci current period net of tax attributable to parent decreased by 66.7% year-over-year, from -$300.00K to -$500.00K.
- What does reclassification from aoci current period net of tax attributable to parent mean?
- The amount of previously unrealized gains or losses now being recognized in current earnings.